Dr. Emanuel Misses the Mark with Latest Industry Attack

Writing for The Atlantic, Dr. Ezekiel Emanuel accuses the biopharmaceutical industry of being “deceptive” when it seeks to explain the cost of prescription drugs. But in making this claim, Dr. Emanuel is guilty of engaging in some of his own acts of deception.
For starters, drug prices are not “extreme.” Data show that the growth in net prices for brand-name medicines—the price drugmakers receive after paying rebates and discounts to insurers and others within the s